상세 보기
CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).
- Shitara, Kohei;
- Janjigian, Yelena Y.;
- Elimova, Elena;
- Zhang, Jun;
- Chen, Ming-Huang;
- ... Lee, Jeeyun;
- 외 6명
Citations
WEB OF SCIENCE
0- 제목
- CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).
- 저자
- Shitara, Kohei; Janjigian, Yelena Y.; Elimova, Elena; Zhang, Jun; Chen, Ming-Huang; Smyth, Elizabeth Catherine; Lee, Jeeyun; Miao, Rui; Liu, Silver; Holmblad, Marielle; Rahma, Osama E.; Xu, Rui-Hua
- 발행일
- 2026-01
- 유형
- Meeting Abstract
- 권
- 44
- 호
- 2_SUPPL
- 페이지
- TPS462 ~ TPS462